The Unexpected Truth About Insmed Inc (INSM) Stock You Need to Know
RBC Capital Mkts has recently initiated Insmed Inc (INSM) stock to Outperform rating, as announced on February 25, 2025, according to Finviz. Earlier, on April 23, 2024, Truist had initiated the stock to Buy, setting a price target of $48. Wolfe Research also initiated Outperform rating with a price target of $42. Additionally, Wells Fargo […]
Could Insmed Inc (INSM) Stock Be on the Verge of a Decline?
RBC Capital Mkts has recently initiated Insmed Inc (INSM) stock to Outperform rating, as announced on February 25, 2025, according to Finviz. Earlier, on April 23, 2024, Truist had initiated the stock to Buy, setting a price target of $48. Wolfe Research also initiated Outperform rating with a price target of $42. Additionally, Wells Fargo […]
Could Insmed Inc (INSM) Stock Take a Sudden Turn for the Worse? Here’s What’s at Stake
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Why Insmed Inc (INSM) Stock Might Just Be the Big Win You Need
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
What’s Behind the -1.03% Drop in Insmed Inc (INSM) Stock? Find Out Now!
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc’s Stock Drama: Could This Be a Game-Changer for INSM Investors?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Why Did Truist Give Insmed Inc (INSM) Stock Buy Rating?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Reported a -205.25% Operating Margin Last Year—What’s the Real Story?
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock: More Resilient Than It Appears
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
Insmed Inc (INSM) Stock Dive: The Hidden Causes Revealed
Truist has recently initiated Insmed Inc (INSM) stock to Buy rating, as announced on April 23, 2024, according to Finviz. Earlier, on February 15, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $42. Wells Fargo also initiated Overweight rating with a price target of $55. Additionally, JP Morgan resumed […]
